These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1411408

  • 1. [Monotherapy with the ACE-inhibitor ramipril or the calcium antagonist nitrendipine in essential hypertension].
    Weidmann P, Frank J, Graf W, Hausammann R, Heuberger T, Kerkhoven P, Probst G, Schudel P, Steinbach C, Müller A.
    Schweiz Med Wochenschr; 1992 Oct 03; 122(40):1497-503. PubMed ID: 1411408
    [Abstract] [Full Text] [Related]

  • 2. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 03; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial.
    Andersen K, Weinberger MH, Egan B, Constance CM, Wright M, Lukashevich V, Keefe DL.
    Cardiovasc Ther; 2010 Dec 03; 28(6):344-9. PubMed ID: 20406241
    [Abstract] [Full Text] [Related]

  • 4. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
    White WB, Cleveland JM, Rolleri RL, Ramipril-Hydrochlorothiazide Study Group.
    J Hum Hypertens; 2008 Aug 03; 22(8):559-68. PubMed ID: 18463672
    [Abstract] [Full Text] [Related]

  • 5. Nitrendipine in older patients with isolated systolic hypertension: second progress report on the SYST-EUR trial.
    Staessen J, Bert P, Bulpitt C, De Cort P, Fagard R, Fletcher A, Kivinen P, Lehtomaki E, Leonetti G, O'Brien E.
    J Hum Hypertens; 1993 Jun 03; 7(3):265-71. PubMed ID: 8345494
    [Abstract] [Full Text] [Related]

  • 6. Amiloride compared with nitrendipine in treatment of essential hypertension.
    Katzman PL, Henningsen NC, Hulthén UL.
    J Hum Hypertens; 1988 Oct 03; 2(3):147-51. PubMed ID: 3236318
    [Abstract] [Full Text] [Related]

  • 7. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB, Lacourciere Y, Gana T, Pascual MG, Smith DH, Albert KS.
    Am Heart J; 2004 Oct 03; 148(4):628-34. PubMed ID: 15459593
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive monotherapy with nitrendipine in general practice.
    Braun H, Weber F.
    J Cardiovasc Pharmacol; 1991 Oct 03; 18 Suppl 1():S59-62. PubMed ID: 1723458
    [Abstract] [Full Text] [Related]

  • 9. Nitrendipine and atenolol in essential hypertension in young and middle-aged patients: effect on serum lipids and left ventricular mass.
    López NC, Corral JL, Rincón LA, Arreaza MR, Giralt J, Galué GA, Barrios YE, Arocha I.
    J Cardiovasc Pharmacol; 1991 Oct 03; 18 Suppl 1():S101-5. PubMed ID: 1723446
    [Abstract] [Full Text] [Related]

  • 10. The acute and chronic effects of nitrendipine on plasma catecholamines in hypertensive patients.
    el-Beheiry H, Ruedy N, Wall RA, Murphy M, Wright JM.
    Can J Cardiol; 1993 Oct 03; 9(1):41-6. PubMed ID: 8439828
    [Abstract] [Full Text] [Related]

  • 11. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W, Cymerys M, Kujawska-Luczak M, Pupek-Musialik D.
    Pol Merkur Lekarski; 2005 Mar 03; 18(105):287-90. PubMed ID: 15997634
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
    Uresin Y, Taylor AA, Kilo C, Tschöpe D, Santonastaso M, Ibram G, Fang H, Satlin A.
    J Renin Angiotensin Aldosterone Syst; 2007 Dec 03; 8(4):190-8. PubMed ID: 18205098
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
    Andersen K, Weinberger MH, Egan B, Constance CM, Ali MA, Jin J, Keefe DL.
    J Hypertens; 2008 Mar 03; 26(3):589-99. PubMed ID: 18300872
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of once daily nitrendipine in mild hypertension: comparison with placebo.
    Fodor JG, Chockalingam A, Cifkova R, Strong HA, Cobby J, Mukherjee J.
    Can J Cardiol; 1991 Jun 03; 7(5):223-8. PubMed ID: 1860094
    [Abstract] [Full Text] [Related]

  • 15. Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension.
    Lafleche A, Gautier S, Topouchian J, Wilmet CS, Girerd X, Safar ME, Benetos A.
    Clin Pharmacol Ther; 1998 Jul 03; 64(1):96-105. PubMed ID: 9695724
    [Abstract] [Full Text] [Related]

  • 16. Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an Italian multicenter study.
    Leonetti G, Salvetti A.
    J Cardiovasc Pharmacol; 1994 Jul 03; 24 Suppl 3():S73-7. PubMed ID: 7700071
    [Abstract] [Full Text] [Related]

  • 17. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb 03; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 18. Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertension.
    Schwartz SL, Hanson C, Lucas C, Rosenblatt S, Rosenstock J, Whittier F, Wistran D, Riche C, Mulcahy WS.
    Clin Ther; 1993 Feb 03; 15(1):79-87. PubMed ID: 8458057
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH, Chung WY, Zo JH, Kim MA, Chang HJ, Cho YS, Youn TJ, Chae IH, Choi DJ, Gwak JJ, Lee HY, Park JS, Kang HJ, Kim YJ, Kim HS.
    Clin Ther; 2009 May 03; 31(5):988-98. PubMed ID: 19539099
    [Abstract] [Full Text] [Related]

  • 20. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov 03; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.